Personalized Prediction of Glaucoma Progression Under Different Target Intraocular Pressure Levels Using Filtered Forecasting Methods.

PURPOSE To generate personalized forecasts of how patients with open-angle glaucoma (OAG) experience disease progression at different intraocular pressure (IOP) levels to aid clinicians with setting personalized target IOPs. DESIGN Secondary analyses using longitudinal data from 2 randomized controlled trials. PARTICIPANTS Participants with moderate or advanced OAG from the Collaborative Initial Glaucoma Treatment Study (CIGTS) or the Advanced Glaucoma Intervention Study (AGIS). METHODS By using perimetric and tonometric data from trial participants, we developed and validated Kalman Filter (KF) models for fast-, slow-, and nonprogressing patients with OAG. The KF can generate personalized and dynamically updated forecasts of OAG progression under different target IOP levels. For each participant, we determined how mean deviation (MD) would change if the patient maintains his/her IOP at 1 of 7 levels (6, 9, 12, 15, 18, 21, or 24 mmHg) over the next 5 years. We also model and predict changes to MD over the same time horizon if IOP is increased or decreased by 3, 6, and 9 mmHg from the level attained in the trials. MAIN OUTCOME MEASURES Personalized estimates of the change in MD under different target IOP levels. RESULTS A total of 571 participants (mean age, 64.2 years; standard deviation, 10.9) were followed for a mean of 6.5 years (standard deviation, 2.8). Our models predicted that, on average, fast progressors would lose 2.1, 6.7, and 11.2 decibels (dB) MD under target IOPs of 6, 15, and 24 mmHg, respectively, over 5 years. In contrast, on average, slow progressors would lose 0.8, 2.1, and 4.1 dB MD under the same target IOPs and time frame. When using our tool to quantify the OAG progression dynamics for all 571 patients, we found no statistically significant differences over 5 years between progression for black versus white, male versus female, and CIGTS versus AGIS participants under different target IOPs (P > 0.05 for all). CONCLUSIONS To our knowledge, this is the first clinical decision-making tool that generates personalized forecasts of the trajectory of OAG progression at different target IOP levels. This approach can help clinicians determine appropriate, personalized target IOPs for patients with OAG.

[1]  A. Azuara-Blanco,et al.  The rising cost of glaucoma drugs , 2006, British Journal of Ophthalmology.

[2]  S. Gardiner,et al.  Examination of different pointwise linear regression methods for determining visual field progression. , 2002, Investigative ophthalmology & visual science.

[3]  J. G. Bogaarts,et al.  EEG Feature Pre-processing for Neonatal Epileptic Seizure Detection , 2014, Annals of Biomedical Engineering.

[4]  E. J. Lefferts,et al.  Kalman Filtering for Spacecraft Attitude Estimation , 1982 .

[5]  J. Wood,et al.  Inferior Field Loss Increases Rate of Falls in Older Adults with Glaucoma , 2011, Optometry and vision science : official publication of the American Academy of Optometry.

[6]  Mariel S. Lavieri,et al.  Dynamic Forecasting and Control Algorithms of Glaucoma Progression for Clinician Decision Support , 2015, Oper. Res..

[7]  R. Ritch,et al.  Visual Field Change and 24-Hour IOP-Related Profile with a Contact Lens Sensor in Treated Glaucoma Patients. , 2016, Ophthalmology.

[8]  J. Ulbrecht,et al.  Personalized State-space Modeling of Glucose Dynamics for Type 1 Diabetes Using Continuously Monitored Glucose, Insulin Dose, and Meal Intake , 2014, Journal of diabetes science and technology.

[9]  William J. Morris,et al.  When to treat prostate cancer patients based on their PSA dynamics , 2012 .

[10]  B. Bengtsson,et al.  Rates of visual field progression in clinical glaucoma care , 2012, Acta ophthalmologica.

[11]  Vikash Gilja,et al.  A closed-loop human simulator for investigating the role of feedback control in brain-machine interfaces. , 2011, Journal of neurophysiology.

[12]  R. E. Kalman,et al.  A New Approach to Linear Filtering and Prediction Problems , 2002 .

[13]  Christoph Ament,et al.  The Unscented Kalman Filter estimates the plasma insulin from glucose measurement , 2011, Biosyst..

[14]  D. Belsky,et al.  Longitudinal rates of postoperative adverse outcomes after glaucoma surgery among medicare beneficiaries 1994 to 2005. , 2008, Ophthalmology.

[15]  D. Rubin,et al.  Maximum likelihood from incomplete data via the EM - algorithm plus discussions on the paper , 1977 .

[16]  B.W. Bequette,et al.  A Dual-Rate Kalman Filter for Continuous Glucose Monitoring , 2006, 2006 International Conference of the IEEE Engineering in Medicine and Biology Society.

[17]  G. Lindgren,et al.  Normal variability of static perimetric threshold values across the central visual field. , 1987, Archives of ophthalmology.

[18]  M. Nicolela,et al.  Rates of glaucomatous visual field change in a large clinical population. , 2014, Investigative ophthalmology & visual science.

[19]  Pooyan Kazemian,et al.  Dynamic Monitoring and Control of Irreversible Chronic Diseases with Application to Glaucoma. , 2019, Production and operations management.

[20]  D E Gaasterland,et al.  The Advanced Glaucoma Intervention Study (AGIS): 1. Study design and methods and baseline characteristics of study patients. , 1994, Controlled clinical trials.

[21]  P. Lichter,et al.  The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients. , 1999, Ophthalmology.

[22]  I. Goldberg,et al.  Depression and Quality of Life in Patients With Glaucoma: A Cross-sectional Analysis Using the Geriatric Depression Scale-15, Assessment of Function Related to Vision, and the Glaucoma Quality of Life-15 , 2008, Journal of glaucoma.

[23]  W Bukhari,et al.  Real-time prediction and gating of respiratory motion using an extended Kalman filter and Gaussian process regression , 2015, Physics in medicine and biology.